30
Participants
Start Date
March 31, 2007
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
Sunitinib Malate
Initially, patients were started on sunitinib at a dose of 50 mg daily. If 50 mg daily resulted in unacceptable toxicity, 2 dose modifications were allowed (to 37.5 and to 25 mg daily, if necessary). Study patients who could not tolerate 25 mg daily of sunitinib were taken off study.
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Collaborators (1)
Pfizer
INDUSTRY
H. Lee Moffitt Cancer Center and Research Institute
OTHER